Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes
Wegovy is also manufactured by Novo Nordisk
Most users notice changes between weeks 3 and 6 of treatment, often after reaching doses of 2mg weekly or higher
The first 8-12 weeks are where the majority of discomfort happens, and it fades from there
That usually means prioritizing protein, doing simple strength training, and avoiding extreme calorie restriction that can backfire
Meshkat S, Di Luciano C, Swiderski A, Li G, Aguilar RJ, Dunkley BT, Reichelt AC, Zhang Y, Greenshaw A, Vermetten E, Jetly R, Dash S, Agarwal SM, Swainson J, Bhat V (2025) Efficacy and Safety of Glucagon-Like Peptide-1 Agonists for Psychiatric Symptoms: A Systematic Review